Meds Coupons

View Deals

8 Coupons

{{collection.name}} .
  • eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .

    county grand jury report finds shortcomings in hepatitis response .

  • .